Last A$0.03 AUD
Change Today +0.001 / 3.12%
Volume 361.9K
As of 12:49 AM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

analytica ltd (ALT) Snapshot

Open
A$0.03
Previous Close
A$0.03
Day High
A$0.03
Day Low
A$0.03
52 Week High
06/3/14 - A$0.05
52 Week Low
10/24/13 - A$0.02
Market Cap
34.8M
Average Volume 10 Days
1.9M
EPS TTM
A$-0.0042
Shares Outstanding
1.1B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ANALYTICA LTD (ALT)

Related News

No related news articles were found.

analytica ltd (ALT) Related Businessweek News

No Related Businessweek News Found

analytica ltd (ALT) Details

Analytica Limited design, develops, and supplies medical devices in Australia. The company’s lead products include PeriCoach, a perineometer device to assist women and their clinicians in treatment of stress urinary incontinence; and ELF2, a medical device that assists neurologist and rehabilitates treatment of muscular spasticity. It also offers the AutoStart Burette Infusion System, which automatically restarts the delivery of intravenous fluid once the burette has dispensed its predetermined amount of liquid or drug. The company is based in Brisbane, Australia.

analytica ltd (ALT) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: A$210.0K
Executive Chairman, Member of Audit & Risk Ma...
Total Annual Compensation: A$75.0K
Executive Director, Chairman of Audit & Risk ...
Total Annual Compensation: A$50.0K
Compensation as of Fiscal Year 2014.

analytica ltd (ALT) Key Developments

Analytica Ltd Announces Composition of its Clinical Advisory Boards in Australia and the United States

Analytica Ltd. announced the composition of its Clinical Advisory Boards in Australia and the United States. Australian CAB consists of: Professor Ajay Rane: Director of Urogynaecology, Townsville Hospital, Director of the Mater Pelvic Research and Education Unit at the Townsville Mater Hospital, Professor of Obstetrics and Gynaecology at James Cook University, Townsville. Dr. Ailsa Wilson Edwards: Urologic surgeon at Continence Matters, Adelaide. Dr. Margaret Sherburn: Senior lecturer, Melbourne University, APA Continence and Women's Health Specialist Physiotherapist, Clinical Head and Manager, Physiotherapy, The Royal Women's Hospital, Melbourne. Dr. Pauline Chiarelli: Associate Professor and Program Convenor for the Discipline of Physiotherapy at Newcastle University (Australia). Kay Talbot: Urological/Incontinence Nurse at Australian Urology Associates (AUA). Kay was a founding member of the Victorian Urological Nurses Society, and the inaugural president and meeting convenor of the Australia and New Zealand Urological Nurses Society. Marietta Mehanni: Pelvic Floor First Ambassador, Australian Fitness Network Ambassador, Fitness Gymstick International Program Coordinator and Master Trainer. The US CAB consists of: Dr. G Willy Davila: Chairman of the Department of Gynaecology and Head of the Section of Urogynaecology and Reconstructive Pelvic Surgery at Cleveland Clinic. Dr. Elizabeth Mueller: Associate Professor, Division Director, Female Pelvic Medicineand Reconstructive Surgery, Fellowship Program Director, Female Pelvic Medicine and Reconstructive Surgery, Medical Director Urogynaecology, Female Pelvic Medicine and Reconstructive Surgery, Urology. Dr. Francie Bernier: RNC Dr. Bernier is on the Nursing Faculty at Shenandoah University in Winchester, Virginia. Dr. Beth Shelly: Pelvic Physical Therapist Educator. Dawn Sandalcidi: Physiotherapist specialising in: pelvic muscle dysfunction (incontinence and pain), orthopedic manual therapy, and TMJ treatment. Mary Drill: Fitness Trainer, Master Trainer and Consultant at Body Mechanics by Drill.

Analytica Ltd. Presents at 2014 Bioshares Biotech Summit, Jul-18-2014 04:40 PM

Analytica Ltd. Presents at 2014 Bioshares Biotech Summit, Jul-18-2014 04:40 PM. Venue: Rydges Lakeland Resort, Queenstown, New Zealand. Speakers: Ross Mangelsdorf, Executive Director, Chairman of Audit & Risk Management Committee and Member of Remuneration Committee.

Analytica Ltd. Announces Management Changes

Analytica Limited has appointed Bryan Dulhunty B.Ec, ACA as Chief Financial Officer, in addition to his role as Company Secretary of Analytica. Bryan is the founder of CoSA Life Sciences, providing Company Secretarial, CFO, general management and strategic advice to life science companies. Bryan has experience in the financial control of Life Science companies previously holding positions of Executive Chairman, Managing Director and CFO roles of various listed life sciences companies. Executive Director Ross Mangelsdorf B.Bus, FCA. has been managing both business development and CFO roles will be able to focus on the business development role.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALT:AU A$0.03 AUD +0.001

ALT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALT.
View Industry Companies
 

Industry Analysis

ALT

Industry Average

Valuation ALT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 39.4x
Price/Book 10.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 48.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANALYTICA LTD, please visit www.analyticamedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.